Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Boc-DL-Pro-OH

    • Product Name Boc-DL-Pro-OH
    • Alias DL-Boc-Proline
    • Einecs 252-360-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    821547

    Product Name Boc-DL-Pro-OH
    Chemical Name tert-Butoxycarbonyl-DL-proline
    Cas Number 101132-80-7
    Molecular Formula C10H17NO4
    Molecular Weight 215.25 g/mol
    Appearance White to off-white crystalline powder
    Purity ≥98%
    Melting Point 95-98°C
    Solubility Soluble in DMSO, methanol
    Storage Temperature 2-8°C

    As an accredited Boc-DL-Pro-OH factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Boc-DL-Pro-OH is supplied in a sealed, amber glass bottle containing 25 grams, with a tamper-evident cap and clear labeling.
    Shipping **Boc-DL-Pro-OH** is shipped in tightly sealed containers, protected from moisture and light to preserve stability. It is handled as a non-hazardous chemical but should be transported according to standard chemical shipping guidelines. Temperature control is recommended, typically shipped at ambient or cool conditions depending on customer requirements and local regulations.
    Storage Boc-DL-Pro-OH should be stored in a tightly sealed container, away from direct sunlight, moisture, and incompatible substances. It is best kept at 2-8°C (refrigerated temperatures) in a dry, well-ventilated area. Protect from heat and sources of ignition. Ensure the storage area is designated for chemicals and labeled appropriately to avoid contamination or accidental misuse.
    Application of Boc-DL-Pro-OH

    Applications of Boc-DL-Pro-OH in Industrial Manufacturing

    Boc-DL-Pro-OH, as a protected amino acid derivative, serves essential roles in advanced organic synthesis and peptide development sectors. Our manufacturing expertise ensures batch-to-batch consistency and traceability, supporting direct integration into demanding downstream applications. Below we detail specific industrial scenarios where this material delivers quantifiable value, with reference to real formulation practices, regulatory frameworks, and end product outcomes.

    1. Peptide Pharmaceutical Intermediate Synthesis

    Boc-DL-Pro-OH functions as a key protected building block in the synthesis of therapeutic peptides, particularly where racemic proline units are required for target molecule design. R&D and commercial scale peptide manufacturers leverage its stable Boc-protected structure to control N-terminal reactivity, reducing byproduct formation during solid phase and liquid phase peptide synthesis. This intermediate stage is central to API development—including peptides for metabolic, oncological, and diagnostic applications—which must consistently meet global regulatory submission requirements.

    Industry compliance standards

    • ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients)
    • 21 CFR Part 210/211 (US FDA cGMP for Finished Pharmaceuticals)
    • EP 2.2.3 (European Pharmacopoeia control of amino acid derivatives in peptide APIs)
    • China Pharmacopoeia (ChP) peptide drug standards

    Typical usage ratio

    • 10–25 mol% relative to total protected amino acids in resin-bound solid-phase peptide synthesis; exact amount adjusted by token sequence architecture and chain length.

    Downstream process integration

    • Introduced during automated or manual SPPS cycles as the N-protected proline monomer, with Fmoc/Boc protocols dictating deprotection sequence; integrated at the primary chain extension or cyclization stage.

    Final product types

    • Pharmaceutical peptide APIs (e.g., glucagon, oxytocin analogs)
    • Peptide-based drug candidates for clinical trials
    • Diagnostics reagents (custom labeled peptides)
    • Research-grade peptide kits

    2. Custom Peptide Reagent Manufacturing for Immunological Assays

    In the production of synthetic peptides for use in immunological assays—such as ELISA kits, epitope mapping, and peptide microarrays—laboratories require robust protection strategies for side-chain functional groups to avoid interference or unexpected cross-reactivity. Boc-DL-Pro-OH is employed to introduce discrete proline motifs, facilitating accurate probe or antigen synthesis. Its role directly impacts assay reproducibility and specificity, crucial for clinical and academic research settings subjected to strict validation practices.

    Industry compliance standards

    • ISO 13485:2016 (Medical Devices—Quality Management Systems for IVD kits)
    • WHO Laboratory Biosafety Manual (peptide reagent standards)
    • GLP (OECD Good Laboratory Practice applicable in R&D use)
    • ISO 9001:2015 (reagent QC standards)

    Typical usage ratio

    • 5–20 mol% of total protected amino acids added per assembled peptide sequence; sequenced according to epitope design and functional group preservation strategy.

    Downstream process integration

    • Applied at defined coupling stages in automated peptide synthesizers, with strict process controls for side-chain deprotection and downstream HPLC purification; custom order production integrates this step upon peptide chain specification receipt.

    Final product types

    • Peptide antigens for immunodiagnostic kits (ELISA, lateral flow devices)
    • Synthetic epitope libraries
    • Peptide-coated plates for T-cell response research
    • Microarray printing stock solutions

    3. Building Block for Combinatorial Chemistry Libraries

    Combinatorial chemistry groups utilize Boc-DL-Pro-OH to diversify peptide or pseudopeptide libraries, essential for drug discovery screening platforms. Its inclusion enables systematic variation at proline positions, which influences molecular folding and binding site mimicry in high-throughput screening pools. Strict records of all input components are maintained to comply with international screening program submission rules and to support downstream IP claims.

    Industry compliance standards

    • GLP (OECD 21/2007—Good Laboratory Practice for study integrity)
    • US NIH Compound Library Submission Guidelines
    • EU REACH Registration (substance pre-qualification for synthesis)
    • ISO 17025:2017 (analytical lab competence for compound certification)

    Typical usage ratio

    • Variable (1–30 mol% depending on library complexity and design matrix); ratio determined by the number of proline sites to be randomized and project-specific diversity indices.

    Downstream process integration

    • Added during parallel solid-phase synthesis or solution-phase split-and-mix protocols as a proline codon; protection group management timed with iterative library growth steps and subsequent unmasking for functional screening.

    Final product types

    • Fragment-based screening libraries
    • Peptidomimetic combinatorial libraries
    • Affinity probe sets for target validation
    • Building blocks for hit-to-lead expansion

    4. Protected Amino Acid Input for Advanced Organic Synthesis (Non-Peptide Applications)

    Some advanced organic synthesis routes exploit Boc-DL-Pro-OH as a chiral or racemic building block to construct small molecules, pseudopeptides, or cyclic compounds that exploit proline’s unique conformational properties. Chemical manufacturers rely on well-characterized Boc protection to enable selective downstream modifications, particularly in the synthesis of specialty fine chemicals and chiral auxiliaries, where maintaining consistent product specification is critical for further use in regulated and audited processes.

    Industry compliance standards

    • ISO 9001:2015 (chemical manufacturing quality control)
    • USP-NF General Chapters (applicable to excipient and intermediate quality)
    • ICH Q11 (Development and Manufacture of Drug Substances—applicable when intermediates are used for API synthesis)
    • Responsible Care® Management System (environmental and process safety)

    Typical usage ratio

    • 0.5–10 wt% in multi-step synthesis pathways, calculated based on step yield, substrate molarity, and target scaffold complexity; frequent pilot scale optimization.

    Downstream process integration

    • Input at the early or mid-stage of synthetic schemes as a protected amino acid precursor; undergoes controlled deprotection or further modification before conversion to cyclic imides, specialty amide derivatives, or as auxiliaries in stereoselective transformations.

    Final product types

    • Cyclic diketopiperazines (intermediates for fine chemicals)
    • Chiral auxiliaries for asymmetric catalysis
    • Advanced precursors in cross-coupling reactions
    • Small-molecule building blocks for high-value chemicals
    Free Quote

    Competitive Boc-DL-Pro-OH prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Boc-DL-Pro-OH: Supporting Reliable Peptide Synthesis from the Factory Floor

    Introducing Boc-DL-Pro-OH: From Production to Laboratory

    Every lot of Boc-DL-Pro-OH that leaves our reactors reflects years of hands-on manufacturing, testing, and process improvement. In organic synthesis, this reagent offers a track record of consistent quality and reliable performance. On the production side, we’ve learned a straightforward truth: reproducibility matters as much in the factory as it does in research labs or pilot plant benches. Peptide chemists—whether academic or industrial—value transparency about purity, precise specification, and just as importantly, predictability from batch to batch. This is where our experience delivering Boc-DL-Pro-OH proves valuable day after day.

    What Sets Boc-DL-Pro-OH Apart in Operation

    Lots of proline derivatives crowd catalogs these days, but Boc-DL-Pro-OH stands out where reactions depend on both reliable protection and structural versatility. Working as a chemical manufacturer means facing real-world variability—raw materials, equipment downtime, weather, and customer urgency. Lessons from thousands of kilos produced help us anticipate challenges. Proline, with its distinctive ring structure, brings conformational effects into peptide design. The Boc group provides sturdy N-terminal protection, and with the DL mixture, users get a mix of both the D- and L- enantiomers. This racemic form appeals to teams probing structure-activity relationships, since side-by-side synthesis with both stereoisomers can move projects forward quickly.

    Over years of experience, we have seen requests for both enantiopure and racemic forms, yet Boc-DL-Pro-OH supports synthetic sequences that are less sensitive to chirality or require comparative screening. Compared to the pure L- or D- isomers, the DL-product supplies a broader user base, so controlling diastereomeric purity and minimizing byproducts has become routine for our team. We always consider real feedback about solubility, ease of handling, and reactivity from scale-up and routine processing—not just the literature data—when tuning our process or validating new lots.

    Production Approach: Why Consistency Beats Claims

    On our manufacturing lines, making Boc-DL-Pro-OH demands careful attention to both protection chemistry and the quirks of proline as a substrate. Proline itself shows unique reactivity because of its cyclic nature, so control over reaction times, pH, and solvent handling determines if a batch lives up to expectations. Each year brings improvements in throughput and waste minimization, yet only so long as consistency in product quality remains at the fore. Many research and pharma customers push for continuous improvement, and they’ll notice even small shifts in melting range, spectral profile, or the shape of the crystalline product. We emphasize in-line monitoring and off-line validation to minimize run-to-run drift. It’s a discipline motivated by real customer outcomes, not just filling a spec sheet.

    Peptide chemists often run small-scale exploratory reactions or large parallel syntheses, so the physical form matters. Whether delivered as a fine powder or free-flowing granule, the Boc-DL-Pro-OH must dissolve evenly and react as expected. Our process keeps particle size distribution tight and controls residual solvents, because these factors impact reproducibility in solid-phase and solution-phase work alike. After each batch, we rely on a set of analytical controls—NMR, IR, HPLC—to monitor for possible side products such as unreacted proline or over-alkylated byproducts. No process runs itself—we have full-time operators tracking every drum leaving the plant.

    Why Purity Tells Only Part of the Story

    Enthusiasts for peptide chemistry sometimes see a specification of 98% or higher and call it a day, but time on the factory floor teaches that the last two percent can decide between smooth synthesis and a frustrating bottleneck. We insist on multi-point analyses because trace impurities can show up as persistent peptide chain deletions or lumpy spots in the resin. Every year, project chemists challenge us with feedback—one reported a novel impurity after long storage, another flagged inconsistent yield in a sensitive bioactive tetrapeptide.

    Our experience shows that purity targets printed on invoices only capture part of what matters to a synthetic operator. Years of collaboration with formulation and analytical chemists inspired tweaks in our protocols—adjusting drying temperatures so residual moisture remains low, changing filtration to eliminate fine particulates, tightening control curves for Boc anhydride additions. These operational improvements don't end up in a published method, but they keep research projects moving on schedule.

    Comparing Boc Protection to Competing Strategies

    Boc-DL-Pro-OH’s backbone reflects a protection approach that’s stood the test of time. On the synthesis bench, Boc (tert-butyloxycarbonyl) offers reliable acid-labile N-protection, cleaving under TFA without harsh side reactions. As a raw material producer, we see continued demand for Fmoc- and CBz-protected forms, each with loyal users and specific workflow advantages. Yet Boc chemistry remains popular because of its compatibility with both traditional and modern peptide synthesizers, as well as its relative affordability.

    Compared with Fmoc-protected proline, Boc-DL-Pro-OH is more tolerant of strong bases during coupling. Many of our customers, especially those conducting older synthesis protocols or dealing with incompatible functional groups, stick to Boc-protection for its reliability and milder deprotection conditions. Of course, automated synthesizers increasingly drive preference for Fmoc, but for manual synthesis, pilot runs, or analog programs where many variants must be rapidly compared, Boc-DL-Pro-OH proves itself time and again.

    Listening to User Experience: From Research Bench to Pilot Plant

    One of the biggest lessons from years of manufacturing Boc-DL-Pro-OH is that no batch leaves our factory in a vacuum. We follow up with customers in pharma labs, CROs, biotech start-ups, and leading research institutes. Problems sometimes arise—not everything goes as planned in the real world, and open communication shortens troubleshooting. If a batch fails to meet a critical purity threshold or fails to dissolve as needed, we investigate with parallel analysis and, if needed, reprocess a new lot.

    Some feedback led to unexpected insights: several customers working in humid regions struggled with clumping in storage, so we revised our drying protocol and improved packaging. Another group, focused on structure-activity relationships in antimicrobial peptides, requested tighter chiral control and benefited from more detailed HPLC data. Requests like these drive us to refine our process. It keeps us honest and moving forward, especially as peptide chemistry branches into ever more ambitious applications in drug discovery and material science.

    Addressing Environmental and Safety Concerns

    Any chemical manufacturing process brings with it environmental responsibilities. Boc chemistry generates not only the desired protected amino acid, but also side-streams like di-tert-butyl dicarbonate and byproducts from proline transformation. Over the years, stricter local regulations for waste water and air quality shaped our operational choices. We invested in upgraded scrubbers, improved solvent recovery units, and catalytic incineration of off-gases. These changes cut not only emissions but also raw material cost and factory footprint.

    The scale at which Boc-DL-Pro-OH is made means every incremental reduction in waste adds up. This product runs through aqueous and organic phases—most of our solvent use now cycles through recovery units, and recovered material passes stringent quality tests before reuse. Waste minimization matters not just for cost, but also for community relations around the plant. Worker safety counts, too. We trained our operators for careful handling of Boc anhydride, which can react violently in the wrong hands, and proline dust, which irritates the lungs. Our on-site safety team tracks incidents and adjusts protocols so that each operator returns home healthy. Experience showed that most accidents occurred not during operations, but during cleaning and maintenance, so our procedures grew more rigorous with time.

    Serving Broad Chemical Needs: Flexibility Without the Middlemen

    As a direct manufacturer, we field requests ranging from gram-scale research samples to metric ton shipments. We ship to peptide research groups, pharmaceutical developers, diagnostic companies, resin manufacturers—each with slightly different technical requirements. The absence of intermediaries means we can adjust purity spec, packaging format, and analytical documentation to fit the end use. Our technical team works alongside operators, so we can provide detailed process insight and history for each delivered lot.

    Having run into urgent customer timelines more times than we can count, our team keeps extra lot samples in reserve and can often expedite delivery in hours, not weeks. Chronic delays often result from resellers losing visibility into real inventory or changes in specification. Our team checks each outgoing order for special requests—double bagging for sensitive labs, smaller containers for automated dispensers, or shipping with custom documentation for international regulations.

    Future Directions: Meeting Advances in Peptide Chemistry

    Staying competitive in manufacturing Boc-DL-Pro-OH involves more than sticking to the old ways. The burst in peptide therapeutics, antibody-drug conjugates, and designer biomaterials brings new demands for purity, tighter impurity profiles, and sustainable production. Recent years brought in-line process analytical technologies into our reactors, giving real-time feedback and reducing the guesswork from process control. We’re moving towards digital tracking for each batch, linking raw material sources with finished product analytics. This approach doesn’t just save time; it satisfies growing demand for traceability in regulated markets.

    Our technical team is collaborating with upstream producers to secure high-quality proline and greener Boc anhydride equivalents. We stay informed about evolving regulatory frameworks on hazardous waste, solvent emissions, and transporter safety. Workshops with R&D chemists keep us abreast of troubleshooting tips and novel synthetic applications that might demand a tweak in process parameters or analytical testing. We know that as synthetic biology and combinatorial chemistry continue to expand, demand for versatile, reliably manufactured intermediates like Boc-DL-Pro-OH will follow.

    Differences from Competing Products

    Chemical catalogs list many protected proline variants—Boc-L-Pro-OH, Boc-D-Pro-OH, Fmoc-Proline derivatives, N-Boc, N-Cbz, and unprotected forms. What distinguishes Boc-DL-Pro-OH isn’t only its racemic composition, but also the cumulative experience and process knowledge invested in manufacturing at scale without cutting corners. Our in-house control captures parameters beyond what’s demanded by generic specs: particle flow, moisture profile, spectroscopic fingerprint, and long-term stability data. This translates to less troubleshooting in synthetic labs, fewer failures in coupling or deprotection steps, and more predictable overall outcomes.

    Boc-DL-Pro-OH’s racemate content distinguishes its role in rapid structure-activity screening, as opposed to chiral-specific analogs that lock a pathway for a single stereochemical outcome. For applications tracking both isomer activities or preparing racemic libraries, the DL form sidesteps the additional cost and complexity of preparing or sourcing both enantiomers separately. Our facility handles the required validation for chiral content and impurity profiling, which matters deeply for high-throughput screening and exploratory medicinal chemistry.

    Supporting Long-Term Partnerships in Peptide Chemistry

    Years working on Boc-protected amino acids brought us something that matters more than simple technical compliance—trust from repeat customers. We’ve learned that transparency, quick response, and responsive technical service hold more weight than clever marketing. Whenever our team reviews customer feedback—missed analytical expectations, synthesis hiccups, or even praise for smooth execution—we use it to refine both plant process and customer support. Most improvements stem not from management edicts, but from day-to-day troubleshooting and dialogue with operators and external partners.

    Being close to the source of production lets us ship fresh lots for sensitive development programs and offer process changes that might not scale for global conglomerates. Researchers and manufacturers who work with us often point out that timely support and batch-to-batch consistency keep their programs on track, a claim that holds up in years of practical delivery rather than catalog promises. Combined expertise from synthesis operators, analytical chemists, and technical support joined with long-term customer relationships drives our steady output of Boc-DL-Pro-OH that matches evolving needs.

    Summary: Why Boc-DL-Pro-OH Means More from the Manufacturer’s Perspective

    Not every chemical becomes indispensable, but Boc-DL-Pro-OH has earned steady, growing demand owing to its contribution to peptide synthesis research and industrial applications. Customers come to direct producers with higher expectations than from anonymous vendors—they want details, flexibility, accountability, and workable solutions for new problems as they arise. Our plant’s long-term experience with Boc-DL-Pro-OH, shaped by thousands of batches and feedback loops, delivers what research and industrial chemists need, and stands as a practical example of how quality and responsiveness go hand-in-hand with chemical manufacturing. Where real-world chemical synthesis meets process improvement, Boc-DL-Pro-OH keeps projects moving, ensures fewer headaches on the bench, and upholds reliable results time and time again.